Manufacturer record

Supercure Biotech Pvt. Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

8 batches manufactured by Supercure Biotech Pvt. Ltd (Haryana) were declared Not of Standard Quality between December 2021 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: C-2873, Omeprazole & Domperidone Capsules IP (exp Sep 2027). LUCKNOW, Uttar Pradesh (state lab) found it not of standard quality: The sample does not conform to IP in respect of Uniformity of Content. Listed in the September 2026 alert.

Records by type

8 records linked to Supercure Biotech Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
8Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Dec 2021 to Sep 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

8
NSQ batches since 2021
6
Products affected
Assay
Most common failure
Sep 2026
Latest alert

Flagged batches per year

2021 · 12026 · 7

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Omeprazole & Domperidone Capsules IP Batch C-2873Mfg Oct 2025 · Exp Sep 2027 The sample does not conform to IP in respect of Uniformity of Content.Uniformity of weight/content LUCKNOW, Uttar PradeshState lab Sep 2026
Loperamide Hydrochloride Tablets IP 2 mg- Batch SBT-3269Mfg Jul 2025 · Exp Jun 2027 Sample does not conform to IP standards. This particular batch of sample fails in the tests'dissolution and assay of Loperamide Hydrochloride.Assay RDTL , ErnakulamState lab Sep 2026
Loperamide Hydrochloride Tablets IP 2 mg Batch SBT3269Mfg Jul 2025 · Exp Jun 2027 Dissolution and Assay of Loperamide HydrochlorideAssay RDTL, EKMState lab Aug 2026
Paracetamol, Phenylephrine HCL, Guaiphenesin, Cetirizine Hydrochloride & Ambroxol HCL Tablets Batch SBT-3351Mfg Jul 2025 · Exp Jun 2027 The sample is found to be Not of Standard Quality for the reason stated under Description.Description CDL, KolkataCDSCO lab Jul 2026
Loperamide Hydrochloride Capsules I.P Batch C-2127Mfg Dec 2024 · Exp Nov 2026 Dissolution TestDissolution DTL, Bengaluru, KarnatakaState lab Apr 2026
ROSE-4 DSR Batch C2269Mfg Jan 2025 · Exp Dec 2026 content of RabeprazoleOther Uttar PradeshState lab Jan 2026
Pantoprazole Sodium Gastro-resistant & Domperidone Prolonged Release Capsule IP Batch C-1594Mfg Feb 2024 · Exp Jan 2026 Assay of DomperidoneAssay Uttar PradeshState lab Jan 2026
Omeprazole Capsule I.P. 20 mg. Batch SBC-20/021Mfg Mar 2020 · Exp Feb 2022 DissolutionDissolution RDTL GuwahatiState lab Dec 2021

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.